山东大学学报 (医学版) ›› 2021, Vol. 59 ›› Issue (6): 5-9.doi: 10.6040/j.issn.1671-7554.0.2021.0467
程晓光1,卢艳慧2
CHENG Xiaoguang1, LU Yanhui2
摘要: 骨质疏松症是一种全身性骨病。骨量减少和骨微结构破坏使骨的脆性增加,最终导致骨折风险增加。按照病因不同可将原发性骨质疏松分为绝经后骨质疏松(PMO)和老年性骨质疏松(SO)。而男性骨质疏松主要为SO,所以男性比女性发病晚。目前骨质疏松诊断主要依据双能X线吸收法(DXA)的T值及DXA的流调结果,显示男性骨质疏松患病率低,因此受到重视不够。另外,目前治疗骨质疏松的药物男性适应证少,造成对男性的骨质疏松防治的忽视。所以应该采用多种检测手段,包括影像检查、DXA和定量CT(QCT)对骨质疏松进行诊断,以及加强人们对男性骨质疏松的认知和对干预的重视。
中图分类号:
[1] Kanis JA, Melton LJ 3rd, Christiansen C, et al. The diagnosis of osteoporosis[J]. J Bone Miner Res, 1994, 9(8): 1137-1141. [2] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中华骨质疏松和骨矿盐疾病杂志, 2017, 10(5): 413-414. [3] Zeng Q, Li N, Wang Q, et al. The prevalence of osteoporosis in China, a nationwide, multicenter DXA survey[J]. J Bone Miner Res, 2019, 34(10): 1789-1797. [4] 程晓光,董剩勇,王亮,等.应用双能X线骨密度仪调查中国人群骨密度水平和骨质疏松症患病率[J].中华健康管理学杂志, 2019, 13(1): 51-58. [5] 中华医学会骨质疏松和骨矿盐疾病分会.男性骨质疏松症诊疗指南[J].中华骨质疏松和骨矿盐疾病杂志, 2020, 13(5): 381-395. [6] Berger C, Goltzman D, Langsetmo L, et al. Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis [J]. J Bone Miner Res, 2010, 25(9): 1948-1957. [7] Si L, Winzenberg TM, Jiang Q, et al. Projection of osteoporosis-related fractures and costs in China: 2010-2050[J]. Osteoporos Int, 2015, 26(7): 1929-1937. [8] Keene GS, Parker MJ, Pryor GA. Mortality and morbidity after hip fractures[J]. BMJ, 1993, 307(6914): 1248-1250. [9] 中华医学会放射学分会骨关节学组,中国医师协会放射医师分会肌骨学组,中华医学会骨科学分会骨质疏松学组,等.骨质疏松的影像学与骨密度诊断专家共识[J].中华放射学杂志, 2020, 54(8): 745-752. [10] Gao C, Xu Y, Li L, et al. Prevalence of osteoporotic vertebral fracture among community-dwelling elderly in Shanghai[J]. Chin Med J(Engl), 2019, 132(14): 1749-1751. [11] Wáng YXJ, Che-Nordin N, Deng M, et al. Osteoporotic vertebral deformity with endplate/cortex fracture is associated with higher further vertebral fracture risk: the Ms. OS(Hong Kong)study results[J]. Osteoporos Int, 2019, 30(4): 897-905. [12] Wang L, Ran L, Zha X, et al. Adjustment of DXA BMD measurements for anthropometric factors and its impact on the diagnosis of osteoporosis[J]. Arch Osteoporos, 2020,15(1): 155. doi: 10.1007/s11657-020-00833-1. [13] Xu XM, Li N, Li K, et al. Discordance in diagnosis of osteoporosis by quantitative computed tomography and dual-energy X-ray absorptiometry in Chinese elderly men[J]. J Orthop Translat, 2018, 18: 59-64. doi: 10.1016/j.jot.2018.11.003. [14] Cheng X, Zhao K, Zha X, et al. Opportunistic screening using low-dose CT and the prevalence of osteoporosis in China: a nationwide, multicenter study[J]. J Bone Miner Res, 2021, 36(3): 427-435. [15] Schousboe JT, Ensrud KE. Opportunistic osteoporosis screening using low-Dose computed tomography(LDCT): promising strategy, but challenges remain[J]. J Bone Miner Res, 2021, 36(3): 425-426. [16] The Lancet Diabetes Endocrinology. Osteoporosis: overlooked in men for too long[J]. Lancet Diabetes Endocrinol, 2021, 9(1):1. doi:10.1016/S2213-8587(20)30408-3. [17] Madeo B, Zirilli L, Caffagni G, et al. The osteoporotic male: overlooked and undermanaged? [J]. Clin Interv Aging, 2007, 2(3): 305-312. [18] Porcelli T, Maffezzoni F, Pezzaioli LC, et al. Male osteoporosis: diagnosis and management-should the treatment and the target be the same as for female osteoporosis? [J]. Eur J Endocrinol, 2020, 183(3): R75-R93. [19] Gillespie LD, Robertson MC, Gillespie WJ, et al. Interventions for preventing falls in older people living in the community[J]. Cochrane Database Syst Rev, 2012, 12(9): CD007146. doi:10.1002/14651858. CD007146.pub3. [20] Kukuljan S, Nowson CA, Sanders KM, et al. Independent and combined effects of calcium vitamin D3 and exercise on bone structure and strength in older men: an 18-month factorial design randomized controlled trial[J]. J Clin Endocrinol Metab, 2011, 96(4): 955-963. [21] Allison SJ, Folland JP, Rennie WJ, et al. High impact exercise increased femoral neck bone mineral density in older men: a randomised unilateral intervention[J]. Bone, 2013, 53(2): 321-328. [22] Boonen S, Reginster JY, Kaufman JM, et al. Fracture risk and zoledronic acid therapy in men with osteoporosis[J]. N Engl J Med, 2012, 367(18): 1714-1723. [23] Orwoll E, Ettinger M, Weiss S, et al. Alendronate for the treatment of osteoporosis in men[J]. N Engl J Med, 2000, 343(9): 604-610. [24] Ringe JD, Dorst A, Faber H, et al. Alendronate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm study[J]. Rheumatol Int, 2004, 24(2): 110-113. [25] Boonen S, Orwoll ES, Wenderoth D, et al. Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study[J]. J Bone Miner Res, 2009, 24(4): 719-725. [26] Ringe JD, Farahmand P, Faber H, et al. Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study[J]. Rheumatol Int, 2009, 29(3): 311-315. [27] Orwoll E, Teglbjærg CS, Langdahl BL, et al. A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density[J]. J Clin Endocrinol Metab, 2012, 97(9): 3161-3169. [28] Langdahl BL, Teglbjærg CS, Ho PR, et al. A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial[J]. J Clin Endocrinol Metab, 2015, 100(4): 1335-1342. [29] Orwoll ES, Scheele WH, Paul S, et al. The effect of teriparatide [human parathyroid hormone(1-34)] therapy on bone density in men with osteoporosis[J]. J Bone Miner Res, 2003, 18(1): 9-17. [30] Kaufman JM, Orwoll E, Goemaere S, et al. Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy[J]. Osteoporos Int, 2005, 16(5): 510-516. |
[1] | 陈诗鸿,姜冬青,庄向华,李晓博,潘喆,孙爱丽,娄能俊,王殿辉,杜娇娇,宋玉文. 以骨痛为首发表现的原发性胆汁性胆管炎1例[J]. 山东大学学报 (医学版), 2022, 60(8): 98-102. |
[2] | 吕丽,姜璐,陈诗鸿,庄向华,宋玉文,王殿辉,安文娟,李倩,潘喆. 210例绝经后2型糖尿病发生骨质疏松的相关因素[J]. 山东大学学报 (医学版), 2021, 59(7): 19-25. |
[3] | 刘萍,宋玉文,王萍,田光伟,郑凤杰,吕丽,杜娇娇,张静,庄向华,陈诗鸿. 维生素D缺乏与2型糖尿病合并抑郁状态的相关性[J]. 山东大学学报 (医学版), 2021, 59(6): 51-56,102. |
[4] | 朱序理,周亮,王跃,孙庆云,曹明雅,杜元杰,曹金凤,赵志明,郝桂敏. 不同精子来源质量冷冻方式与妊娠结局的关联性分析[J]. 山东大学学报 (医学版), 2021, 59(6): 86-93. |
[5] | 罗湘杭,周若玙. 骨质疏松的病因及发病机制研究进展[J]. 山东大学学报 (医学版), 2021, 59(6): 10-15. |
[6] | 陈诗鸿. 糖皮质激素性骨质疏松症研究进展[J]. 山东大学学报 (医学版), 2021, 59(6): 33-37. |
[7] | 邢小平. 原发性骨质疏松症诊治思考[J]. 山东大学学报 (医学版), 2021, 59(6): 1-4. |
[8] | 杜娇娇,庄向华,陈诗鸿,王雪萌,姜冬青,吴菲,韩晓琳,华梦羽,宋玉文. 绝经后骨质疏松症患者血清IL-31、IL-33表达变化[J]. 山东大学学报 (医学版), 2021, 59(6): 45-50. |
[9] | 李敏启,杜娟,杨盼盼,寇雨莹,柳珊珊. 氧化应激调控骨质疏松症的研究进展[J]. 山东大学学报 (医学版), 2021, 59(6): 16-24. |
[10] | 林玉玺,李传玺,王霖,马伟. 男男性行为人群性取向告知与艾滋病病毒检测:社会规范与自我效能的链式中介作用[J]. 山东大学学报 (医学版), 2021, 59(3): 113-119. |
[11] | 赵立红,赵书平,聂升刚,孙晶,姜同峰. 507例男性生殖道感染病原体分布及耐药特征[J]. 山东大学学报 (医学版), 2021, 59(1): 55-58. |
[12] | 康成为,刘雷,蒲小兵,谭钢,董长超,晏兆魁. 合并亚临床型甲状腺功能减退的骨质疏松症62例患者骨代谢及骨转换标志物水平分析[J]. 山东大学学报 (医学版), 2020, 58(5): 82-86. |
[13] | 李娜,张志勉. 138例39~81岁体检人员血管钙化指标的关联分析[J]. 山东大学学报 (医学版), 2020, 58(2): 85-89. |
[14] | 徐晓芳,薛明玥,吕高荣,侯芳艳,厉萍. 心理资本在不孕不育夫妇中男性正念与心理困扰间的中介作用[J]. 山东大学学报 (医学版), 2019, 57(2): 105-109. |
[15] | 马刚,许超. 克氏综合征的生育相关研究进展[J]. 山东大学学报 (医学版), 2019, 57(10): 67-73. |
|